Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2002 3
2003 3
2004 4
2005 13
2006 8
2007 3
2008 2
2009 2
2010 5
2011 4
2012 10
2013 12
2014 8
2015 10
2016 9
2017 12
2018 13
2019 15
2020 7
2021 16
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD, Gordon-Mitchell S, Von Ahrens D, Pradhan K, Steeples V, Kim S, Steidl U, Walter M, Fraser IDC, Kulkarni A, Salomonis N, Komurov K, Boultwood J, Verma A, Starczynowski DT. Smith MA, et al. Among authors: steidl u. Nat Cell Biol. 2019 May;21(5):640-650. doi: 10.1038/s41556-019-0314-5. Epub 2019 Apr 22. Nat Cell Biol. 2019. PMID: 31011167 Free PMC article.
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.
Carvajal LA, Neriah DB, Senecal A, Benard L, Thiruthuvanathan V, Yatsenko T, Narayanagari SR, Wheat JC, Todorova TI, Mitchell K, Kenworthy C, Guerlavais V, Annis DA, Bartholdy B, Will B, Anampa JD, Mantzaris I, Aivado M, Singer RH, Coleman RA, Verma A, Steidl U. Carvajal LA, et al. Among authors: steidl u. Sci Transl Med. 2018 Apr 11;10(436):eaao3003. doi: 10.1126/scitranslmed.aao3003. Sci Transl Med. 2018. PMID: 29643228 Free PMC article.
Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.
Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner JM, Will B, Nerlov C, Steidl U, Manz MG, Schroeder T, Passegué E. Pietras EM, et al. Among authors: steidl u. Nat Cell Biol. 2016 Jun;18(6):607-18. doi: 10.1038/ncb3346. Epub 2016 Apr 25. Nat Cell Biol. 2016. PMID: 27111842 Free PMC article.
Stem cell origins of JMML.
Sundaravel S, Steidl U. Sundaravel S, et al. Among authors: steidl u. J Exp Med. 2021 Feb 1;218(2):e20202152. doi: 10.1084/jem.20202152. J Exp Med. 2021. PMID: 33427877 Free PMC article.
Transcriptional circuit dynamics in HSPCs.
Tatsumi G, Steidl U. Tatsumi G, et al. Among authors: steidl u. Blood. 2021 Oct 21;138(16):1382-1384. doi: 10.1182/blood.2021012452. Blood. 2021. PMID: 34673950 No abstract available.
Mechanisms and therapeutic prospects of thrombopoietin receptor agonists.
Bussel J, Kulasekararaj A, Cooper N, Verma A, Steidl U, Semple JW, Will B. Bussel J, et al. Among authors: steidl u. Semin Hematol. 2019 Oct;56(4):262-278. doi: 10.1053/j.seminhematol.2019.09.001. Epub 2019 Oct 19. Semin Hematol. 2019. PMID: 31836033 Review.
STAT3 inhibition as a therapeutic strategy for leukemia.
Kanna R, Choudhary G, Ramachandra N, Steidl U, Verma A, Shastri A. Kanna R, et al. Among authors: steidl u. Leuk Lymphoma. 2018 Sep;59(9):2068-2074. doi: 10.1080/10428194.2017.1397668. Epub 2017 Nov 22. Leuk Lymphoma. 2018. PMID: 29164994 Review.
152 results